CTR-AB.SE - Key Persons
Job Titles:
- Honorary Chairman of the Board
- Associate Professor in Pharmacokinetics
Bengt Dahlström is Associate Professor in Pharmacokinetics and Drug Therapy from Uppsala University, Sweden and has published over 50 scientific papers in this area. He is an expert in pharmacokinetics, drug research and development with over 40 years experience from leading positions in Pharmaceutical companies and CROs. He is co-founder of 3 leading Clinical Research Organizations: CTC AB, PMC AB and MiniDoc AB.
Job Titles:
- Chairman of the Board
- Investment Director at the Sixth Swedish National Pension Fund
Hans is Investment Director at the Sixth Swedish National Pension Fund. He has 35 years' operational and investment experience from the life science industry including a tenure as management consultant at ADL, various senior management positions at Pharmacia & Upjohn and partner at Scandinavian Life Science Venture. Hans has broad international work and board experience of building companies in a changing environment.
Katarina has over 25 years of experience from senior executive positions within healthcare, care and education - among others Apoteket AB, Carema AB, Atvexa AB.
Peter Weiderman is an entrepreneur and investor with a business degree from Uppsala University. He has over 30 years of experience from investing and executive positions. 2005 he founded the investment company Atnotera AB, investing in healthcare, care and education. Cofounder of among others Ambea, Atvexa, Vårdapoteket and Atviva.
As of March 1, 2022, Suzanne Iverson Hemberg will succeed Elinor Hahne and be appointed the new CEO for Toxicology Knowledge Team AB (TKT) in Sweden. Suzanne brings over 20 years of strong leadership as a Senior Scientist and Director of laboratory- and...